Parkinson's

Pharmaceutical Leader Advances Parkinson’s Therapies with Competitive Intelligence

Sedulo GroupCase Studies

The Situation ____________ A Pharmaceutical company with an FDA-approved treatment for Dyskinesia in Parkinson’s patients aimed to strategically expand into therapies for off-episodes. To effectively navigate an evolving and competitive treatment landscape, the client needed continuous, detailed insights into clinical and commercial developments. The Solution ____________ Sedulo Group designed a tailored early warning monitoring program, combining meticulous analysis of press …

PAH

Global 2000 Pharma Company Partners with Sedulo for PAH Competitive Landscape Intelligence

Sedulo GroupCase Studies

The Situation ____________ After receiving two new patents on one of their marketed drugs, a Global 2000 pharmaceutical company sought to partner with a highly-qualified competitive strategy firm that could deliver up-to-date, fully-validated intelligence on competitors’ plans to develop a related product for PAH. The client engaged Sedulo to build a competitive landscape for PAH. The Solution ____________ In order …